Gene Editing Medical Research Disease Prevention Organ Donation Clinical Studies Cancer Treatment Clinical Research Genetic Engineering Gastrointestinal Symptoms Post-Transplant Recovery
It leverages CRISPR/Cas9 disruption of the interferon-γ receptor to boost CAR-T cell durability ahead of planned solid tumor trials.